TNFSF11 and major depressive disorder: In conclusion, it could be inferred that the OPG/RANKL ratio in the blood of MDD patients might be a potential biomarker for assessing the antidepressant effects of (R)- and (R, S)-ketamine, which is crucial for diagnosis (Zhang et al., 2018b).